Recessive hereditary methemoglobinemia: Two novel mutations in the NADH-cytochrome b5 reductase gene

Elisa Fermo, Paola Bianchi, Cristina Vercellati, Anna Paola Marcello, Massimo Garatti, Ornella Marangoni, Wilma Barcellini, Alberto Zanella

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

We report the clinical and molecular characteristics of 6 new patients with recessive hereditary methemoglobinemia due to cytochrome b5 reductase deficiency. One patient was affected by Type-II disease with cyanosis and severe progressive neurological dysfunction, whereas the others displayed the benign Type-I phenotype. Methemoglobin levels ranged from 12.1% to 26.2% and cytochrome b5 reductase activity from 0 to 10% of normal. Eight different mutations were detected among the twelve mutated alleles identified, one splicing mutation, two stop codon, and five missense. Two mutations c. 82 C>T(Gln27STOP) and c. 136 C>T(Arg45Trp) are new. Prenatal diagnosis was performed in the family with Type-II disease.

Original languageEnglish
Pages (from-to)50-55
Number of pages6
JournalBlood cells, molecules & diseases
Volume41
Issue number1
DOIs
Publication statusPublished - Jul 2008

Fingerprint

Cytochrome-B(5) Reductase
Methemoglobinemia
Cytochrome Reductases
Cytochromes b5
Mutation
Genes
Methemoglobin
Cyanosis
Terminator Codon
Prenatal Diagnosis
Alleles
Phenotype

Keywords

  • Cytochrome b5 reductase deficiency
  • DIA1 gene
  • Methemoglobinemia
  • Mutations

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine
  • Hematology

Cite this

Recessive hereditary methemoglobinemia : Two novel mutations in the NADH-cytochrome b5 reductase gene. / Fermo, Elisa; Bianchi, Paola; Vercellati, Cristina; Marcello, Anna Paola; Garatti, Massimo; Marangoni, Ornella; Barcellini, Wilma; Zanella, Alberto.

In: Blood cells, molecules & diseases, Vol. 41, No. 1, 07.2008, p. 50-55.

Research output: Contribution to journalArticle

@article{e6a841f8d9e04cf6af5ed7a170bbd126,
title = "Recessive hereditary methemoglobinemia: Two novel mutations in the NADH-cytochrome b5 reductase gene",
abstract = "We report the clinical and molecular characteristics of 6 new patients with recessive hereditary methemoglobinemia due to cytochrome b5 reductase deficiency. One patient was affected by Type-II disease with cyanosis and severe progressive neurological dysfunction, whereas the others displayed the benign Type-I phenotype. Methemoglobin levels ranged from 12.1{\%} to 26.2{\%} and cytochrome b5 reductase activity from 0 to 10{\%} of normal. Eight different mutations were detected among the twelve mutated alleles identified, one splicing mutation, two stop codon, and five missense. Two mutations c. 82 C>T(Gln27STOP) and c. 136 C>T(Arg45Trp) are new. Prenatal diagnosis was performed in the family with Type-II disease.",
keywords = "Cytochrome b5 reductase deficiency, DIA1 gene, Methemoglobinemia, Mutations",
author = "Elisa Fermo and Paola Bianchi and Cristina Vercellati and Marcello, {Anna Paola} and Massimo Garatti and Ornella Marangoni and Wilma Barcellini and Alberto Zanella",
year = "2008",
month = "7",
doi = "10.1016/j.bcmd.2008.02.002",
language = "English",
volume = "41",
pages = "50--55",
journal = "Blood Cells, Molecules, and Diseases",
issn = "1079-9796",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Recessive hereditary methemoglobinemia

T2 - Two novel mutations in the NADH-cytochrome b5 reductase gene

AU - Fermo, Elisa

AU - Bianchi, Paola

AU - Vercellati, Cristina

AU - Marcello, Anna Paola

AU - Garatti, Massimo

AU - Marangoni, Ornella

AU - Barcellini, Wilma

AU - Zanella, Alberto

PY - 2008/7

Y1 - 2008/7

N2 - We report the clinical and molecular characteristics of 6 new patients with recessive hereditary methemoglobinemia due to cytochrome b5 reductase deficiency. One patient was affected by Type-II disease with cyanosis and severe progressive neurological dysfunction, whereas the others displayed the benign Type-I phenotype. Methemoglobin levels ranged from 12.1% to 26.2% and cytochrome b5 reductase activity from 0 to 10% of normal. Eight different mutations were detected among the twelve mutated alleles identified, one splicing mutation, two stop codon, and five missense. Two mutations c. 82 C>T(Gln27STOP) and c. 136 C>T(Arg45Trp) are new. Prenatal diagnosis was performed in the family with Type-II disease.

AB - We report the clinical and molecular characteristics of 6 new patients with recessive hereditary methemoglobinemia due to cytochrome b5 reductase deficiency. One patient was affected by Type-II disease with cyanosis and severe progressive neurological dysfunction, whereas the others displayed the benign Type-I phenotype. Methemoglobin levels ranged from 12.1% to 26.2% and cytochrome b5 reductase activity from 0 to 10% of normal. Eight different mutations were detected among the twelve mutated alleles identified, one splicing mutation, two stop codon, and five missense. Two mutations c. 82 C>T(Gln27STOP) and c. 136 C>T(Arg45Trp) are new. Prenatal diagnosis was performed in the family with Type-II disease.

KW - Cytochrome b5 reductase deficiency

KW - DIA1 gene

KW - Methemoglobinemia

KW - Mutations

UR - http://www.scopus.com/inward/record.url?scp=44649150258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44649150258&partnerID=8YFLogxK

U2 - 10.1016/j.bcmd.2008.02.002

DO - 10.1016/j.bcmd.2008.02.002

M3 - Article

C2 - 18343696

AN - SCOPUS:44649150258

VL - 41

SP - 50

EP - 55

JO - Blood Cells, Molecules, and Diseases

JF - Blood Cells, Molecules, and Diseases

SN - 1079-9796

IS - 1

ER -